VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1580229
Sex: M
Age: 63
State: FL

Vax Date: 01/06/2021
Onset Date: 01/13/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: extremely red; would scratch and they would bleed; noticed a little petechiae; very itchy on his lower legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (extremely red), SKIN HAEMORRHAGE (would scratch and they would bleed), PETECHIAE (noticed a little petechiae) and PRURITUS (very itchy on his lower legs) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF), CLONAZEPAM, CLONAZEPAM and CLONAZEPAM for an unknown indication. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced ERYTHEMA (extremely red), SKIN HAEMORRHAGE (would scratch and they would bleed), PETECHIAE (noticed a little petechiae) and PRURITUS (very itchy on his lower legs). At the time of the report, ERYTHEMA (extremely red) outcome was unknown and SKIN HAEMORRHAGE (would scratch and they would bleed), PETECHIAE (noticed a little petechiae) and PRURITUS (very itchy on his lower legs) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.

Other Meds: FLOMAX RELIEF; CLONAZEPAM; CLONAZEPAM; CLONAZEPAM

Current Illness:

ID: 1580230
Sex: F
Age: 66
State: PA

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Arm was red and burning; Arm was red and burning; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm was red and burning) and PAIN IN EXTREMITY (Arm was red and burning) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm was red and burning) and PAIN IN EXTREMITY (Arm was red and burning). At the time of the report, ERYTHEMA (Arm was red and burning) and PAIN IN EXTREMITY (Arm was red and burning) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580231
Sex: F
Age: 60
State: NY

Vax Date: 01/20/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: arm got extremely swollen; also felt really sick; (arm) red; (arm) hot; (arm) painful; headache; fatigued; (arm) itchy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm got extremely swollen), MALAISE (also felt really sick), ERYTHEMA ((arm) red), SKIN BURNING SENSATION ((arm) hot) and VACCINATION SITE PAIN ((arm) painful) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in March 2020. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm got extremely swollen), MALAISE (also felt really sick), ERYTHEMA ((arm) red), SKIN BURNING SENSATION ((arm) hot), VACCINATION SITE PAIN ((arm) painful), HEADACHE (headache), FATIGUE (fatigued) and INJECTION SITE PRURITUS ((arm) itchy). At the time of the report, PERIPHERAL SWELLING (arm got extremely swollen), MALAISE (also felt really sick), ERYTHEMA ((arm) red), SKIN BURNING SENSATION ((arm) hot), VACCINATION SITE PAIN ((arm) painful), HEADACHE (headache), FATIGUE (fatigued) and INJECTION SITE PRURITUS ((arm) itchy) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: ??-mar-2021 Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1580232
Sex: M
Age: 31
State: NY

Vax Date: 12/31/2020
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Severe Covid-19 vaccine reaction; hives breaking out on his face; rash on rest of his body; itchiness; . This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (Severe Covid-19 vaccine reaction), URTICARIA (hives breaking out on his face), RASH (rash on rest of his body) and PRURITUS (itchiness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History Information was reported. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), MONTELUKAST SODIUM (SINGULAIR) and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication. On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Severe Covid-19 vaccine reaction), URTICARIA (hives breaking out on his face), RASH (rash on rest of his body) and PRURITUS (itchiness). The patient was treated with PREDNISONE for Adverse event, at a dose of 10 mg and METHYLPREDNISOLONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Severe Covid-19 vaccine reaction), URTICARIA (hives breaking out on his face), RASH (rash on rest of his body) and PRURITUS (itchiness) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient went to Urgent care after 2 or 3 days after the events. Patient was prescribed Prednisone. Then, Patient went to his primary care provider (PCP). Patient was prescribed Methylprednisolone and was informed to see any differences in 48-72 hours. Patient followed up with PCP again and as prescribed Prednisone 10 mg on a tapering schedule. Patient was also referred to see Allergist. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Jan-2021 and was forwarded to Moderna on 03-Feb-2021. . This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (Severe Covid-19 vaccine reaction), URTICARIA (hives breaking out on his face), RASH (rash on rest of his body) and PRURITUS (itchiness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History Information was reported. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), MONTELUKAST SODIUM (SINGULAIR) and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication. On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Severe Covid-19 vaccine reaction), URTICARIA (hives breaking out on his face), RASH (rash on rest of his body) and PRURITUS (itchiness). The patient was treated with PREDNISONE for Adverse event, at a dose of 10 mg and METHYLPREDNISOLONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Severe Covid-19 vaccine reaction), URTICARIA (hives breaking out on his face), RASH (rash on rest of his body) and PRURITUS (itchiness) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient went to Urgent care after 2 or 3 days after the events. Patient was prescribed Prednisone. Then, Patient went to his primary care provider (PCP). Patient was prescribed Methylprednisolone and was informed to see any differences in 48-72 hours. Patient followed up with PCP again and as prescribed Prednisone 10 mg on a tapering schedule. Patient was also referred to see Allergist.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; SINGULAIR; ALLEGRA

Current Illness:

ID: 1580233
Sex: F
Age: 75
State: MD

Vax Date: 01/22/2021
Onset Date: 01/29/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: bump on neck; rash on neck; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLISTER (bump on neck) and RASH (rash on neck) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced BLISTER (bump on neck) and RASH (rash on neck). At the time of the report, BLISTER (bump on neck) and RASH (rash on neck) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580234
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Supraclavicular lymph node swelling; A spontaneous report was received from an other healthcare professional concerning a female patient of an unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced supraclavicular lymph node swelling. The patient's medical history was not provided. No relevant concomitant medications were reported. The patient received their first of two planned doses of mRNA-1273 (batch number: Unknown) on an unknown date. On an unknown date, the patient received their second of two planned doses of mRNA-1273 (batch number: Unknown) for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced supraclavicular lymph node swelling. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of event supraclavicular lymph node swelling was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1580235
Sex: F
Age: 70
State: FL

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: arm was really sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was really sore) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was really sore). The patient was treated with NAPROXEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm was really sore) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.

Other Meds:

Current Illness:

ID: 1580236
Sex: F
Age: 50
State: MA

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Itchy ears; Itchy nose; itchy face; Itchy mouth; Muscle pain; Joint pain; Flowing lips; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION COMPLICATION (Flowing lips), PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face) and ORAL PRURITUS (Itchy mouth) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION COMPLICATION (Flowing lips). On 29-Jan-2021, the patient experienced PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face), ORAL PRURITUS (Itchy mouth), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). The patient was treated with CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and DICLOFENAC RESINATE (ZOTAC) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Flowing lips), PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face), ORAL PRURITUS (Itchy mouth), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1580237
Sex: U
Age:
State:

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: severe body ache; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (severe body ache), PYREXIA (fever) and CHILLS (chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced MYALGIA (severe body ache), PYREXIA (fever) and CHILLS (chills). At the time of the report, MYALGIA (severe body ache), PYREXIA (fever) and CHILLS (chills) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580238
Sex: M
Age: 76
State: AZ

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: gout attack; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (gout attack) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. Concurrent medical conditions included Gout, Hypertension, Cholesterol and Asthma. Concomitant products included MONTELUKAST for Asthma, ROSUVASTATIN CALCIUM (CRESTOR) for Cholesterol, ALOPURINOL for Gout, BENAZEPRIL for Hypertension. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced GOUT (gout attack). At the time of the report, GOUT (gout attack) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Treatment medication was taken by patient but doctor prescribed Colchicine.

Other Meds: ALOPURINOL; BENAZEPRIL; CRESTOR; MONTELUKAST

Current Illness: Asthma; Cholesterol; Gout; Hypertension

ID: 1580239
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: I just recently had COVID 11 days after I've been vaccinated with your product; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of COVID-19 (I just recently had COVID 11 days after I've been vaccinated with your product) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (I just recently had COVID 11 days after I've been vaccinated with your product). At the time of the report, COVID-19 (I just recently had COVID 11 days after I've been vaccinated with your product) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580240
Sex: F
Age:
State: ND

Vax Date:
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: red patch at the injection site; arm itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red patch at the injection site) and VACCINATION SITE PRURITUS (arm itchy) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red patch at the injection site) and VACCINATION SITE PRURITUS (arm itchy). At the time of the report, VACCINATION SITE ERYTHEMA (red patch at the injection site) and VACCINATION SITE PRURITUS (arm itchy) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580241
Sex: F
Age: 91
State: CA

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Lump at injection site; Redness at injection site; Rash at injection site; Soreness in her arm after the injection; This spontaneous case was reported by a consumer and describes the occurrence of in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580242
Sex: F
Age: 75
State: CA

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Slight movement pain in the same arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Slight movement pain in the same arm of the injection) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PAIN (Slight movement pain in the same arm of the injection). At the time of the report, VACCINATION SITE PAIN (Slight movement pain in the same arm of the injection) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580243
Sex: F
Age:
State:

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Arm very sore; Tenderness in joints; Swelling in joints; Pain in the armpit; Arm very red; Arm warm to the touch; Achenes in joints; Heat in the armpit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit) and ERYTHEMA (Arm very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit), ERYTHEMA (Arm very red), VACCINATION SITE WARMTH (Arm warm to the touch), ARTHRALGIA (Achenes in joints) and HEAT EXHAUSTION (Heat in the armpit). At the time of the report, PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit), ERYTHEMA (Arm very red), VACCINATION SITE WARMTH (Arm warm to the touch), ARTHRALGIA (Achenes in joints) and HEAT EXHAUSTION (Heat in the armpit) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580244
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Reporting a side effects from the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Reporting a side effects from the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Reporting a side effects from the vaccine). At the time of the report, ADVERSE EVENT (Reporting a side effects from the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1580245
Sex: M
Age: 41
State: TX

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Fever / Fever of 38 degrees; fever; Chills; Fatigued; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 38 (Inconclusive) Fever of 38 degrees. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580246
Sex: F
Age: 48
State: FL

Vax Date: 01/06/2021
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Symptomatic COVID Positive Test Post First Dose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced COVID-19 (Symptomatic COVID Positive Test Post First Dose). On 02-Feb-2021, COVID-19 (Symptomatic COVID Positive Test Post First Dose) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580247
Sex: F
Age: 57
State: CA

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Injection Site reactions are getting worst; itching on the Injection Site; Injection Site looks like Bee-Sting; Swollen Injection Site; Red Injection Site 2; A little Sore Throat; More sore at the injection site; Little Soreness at the Injection Site; Redness at the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Little Soreness at the Injection Site), ERYTHEMA (Redness at the Injection Site), INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site) and INJECTION SITE REACTION (Injection Site looks like Bee-Sting) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced ARTHRALGIA (Little Soreness at the Injection Site) and ERYTHEMA (Redness at the Injection Site). On 29-Jan-2021, the patient experienced INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site), INJECTION SITE REACTION (Injection Site looks like Bee-Sting), INJECTION SITE SWELLING (Swollen Injection Site), INJECTION SITE ERYTHEMA (Red Injection Site 2), OROPHARYNGEAL PAIN (A little Sore Throat) and INJECTION SITE PAIN (More sore at the injection site). On 23-Jan-2021, ARTHRALGIA (Little Soreness at the Injection Site) and ERYTHEMA (Redness at the Injection Site) had resolved. At the time of the report, INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site), INJECTION SITE REACTION (Injection Site looks like Bee-Sting), INJECTION SITE SWELLING (Swollen Injection Site), INJECTION SITE ERYTHEMA (Red Injection Site 2), OROPHARYNGEAL PAIN (A little Sore Throat) and INJECTION SITE PAIN (More sore at the injection site) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580248
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Everything hurts; Sweats; Horrible fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills). At the time of the report, PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Pyrexia: 92 (Inconclusive) 92F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills). At the time of the report, PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Pyrexia: 92 (Inconclusive) 92F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580249
Sex: F
Age: 78
State:

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. Concomitant products included LEVOTHYROXINE for an unknown indication. On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication included antidepressants.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1580250
Sex: F
Age: 78
State:

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). On 01-Feb-2021, CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) had resolved. Not Provided No medical history, concomitant medication or treatment information was reported.

Other Meds:

Current Illness:

ID: 1580251
Sex: F
Age: 48
State:

Vax Date: 01/06/2021
Onset Date: 01/24/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: SKIN DECOLORATION; HOT TO THE TOUCH INJECTION SITE; ITCHINESS AT INJECTION SITE; RASH AT INJECTION SITE; REDNESS AT INJECTION SITE; SHORTNESS OF BREATH; HEART PALPITATIONS; This spontaneous case was reported by a health care professional and describes the occurrence of DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), SKIN DISCOLOURATION (SKIN DECOLORATION), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE) and INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medically reported history provided by the reporter. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE), INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE), INJECTION SITE RASH (RASH AT INJECTION SITE) and INJECTION SITE ERYTHEMA (REDNESS AT INJECTION SITE). On 28-Jan-2021, the patient experienced SKIN DISCOLOURATION (SKIN DECOLORATION). The patient was treated with CORTISONE at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), SKIN DISCOLOURATION (SKIN DECOLORATION), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE), INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE), INJECTION SITE RASH (RASH AT INJECTION SITE) and INJECTION SITE ERYTHEMA (REDNESS AT INJECTION SITE) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: An additional document received on 16 Apr 2021 included reported email address updated

Other Meds: MULTIVITAMINS [VITAMINS NOS]

Current Illness:

ID: 1580252
Sex: F
Age: 50
State: FL

Vax Date: 01/18/2021
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Tested positive for COVID-19; A spontaneous report was received from a consumer concerning a 50-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and tested positive for covid-19. The patient's medical history was not provided. Concomitant medications included garlic, vitamin D3, bupropion hydrochloride, estradiol, progesterone, (ascorbic acid, ergocalciferol, nicotinamide, retinol palmitate, riboflavin, thiamine mononitrate), valacyclovir, useritin, NAC supplement and zinc. On 18 Jan 2021, approximately five day prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (batch number: 013L2OA) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 22 Jan 2021, the patient tested positive for covid-19. The patient did not receive any treatment. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event tested positive for covid-19 was not reported.; Reporter's Comments: Very limited information regarding the events has been provided at this time. Further information has been requested.

Other Meds: GARLIC [ALLIUM SATIVUM]; VITAMIN D3; WELLBUTRIN; ESTROGEN; PROGESTERONE; MULTIVITAMIN 6; VALACYCLOVIR HCL; ZINC

Current Illness:

ID: 1580253
Sex: F
Age: 63
State: NJ

Vax Date: 01/12/2021
Onset Date: 01/20/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COVID-19 (got sick with COVID) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included Hydrocortisone and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced COVID-19 (got sick with COVID). The patient was treated with METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) at an unspecified dose and frequency. At the time of the report, COVID-19 (got sick with COVID) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. IV fluids, Solumedrol used as a treatment medication

Other Meds: Hydrocortisone; SYNTHROID

Current Illness:

ID: 1580254
Sex: F
Age: 74
State: CA

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Pain at Injection arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain at Injection arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (Pain at Injection arm). At the time of the report, INJECTION SITE PAIN (Pain at Injection arm) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1580255
Sex: M
Age:
State:

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: It is lower jaw that is swollen; Lower teeth has pain there / it has gotten worse since Saturday; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (It is lower jaw that is swollen) and TOOTHACHE (Lower teeth has pain there / it has gotten worse since Saturday) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The patient's past medical history included No adverse event (No Historical condition reported.). On 23-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (It is lower jaw that is swollen) and TOOTHACHE (Lower teeth has pain there / it has gotten worse since Saturday). At the time of the report, SWELLING FACE (It is lower jaw that is swollen) and TOOTHACHE (Lower teeth has pain there / it has gotten worse since Saturday) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided. No relevant concomitant medications were reported. Upon in internal review on 21 May 2021, the age was corrected to unknown age.

Other Meds:

Current Illness:

ID: 1580256
Sex: F
Age: 74
State: CA

Vax Date: 01/19/2021
Onset Date: 01/29/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: my arm turned beet red; arm started to itch; swollen; hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (my arm turned beet red), VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch). On 30-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (my arm turned beet red). At the time of the report, INJECTION SITE ERYTHEMA (my arm turned beet red), VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580257
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID arm) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (COVID arm). At the time of the report, VACCINATION COMPLICATION (COVID arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580258
Sex: F
Age: 78
State:

Vax Date: 01/12/2021
Onset Date: 01/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: pains in her left side about 2 inches above her waist that went around to her back; shingles; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pains in her left side about 2 inches above her waist that went around to her back) and HERPES ZOSTER (shingles) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026l20A) for COVID-19 vaccination. The patient's past medical history included Cancer and Lymphedema. Concomitant products included LISINOPRIL and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced MYALGIA (pains in her left side about 2 inches above her waist that went around to her back) and HERPES ZOSTER (shingles). The patient was treated with FAMCICLOVIR at an unspecified dose and frequency. At the time of the report, MYALGIA (pains in her left side about 2 inches above her waist that went around to her back) and HERPES ZOSTER (shingles) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: LISINOPRIL; LIPITOR

Current Illness:

ID: 1580259
Sex: F
Age: 78
State: FL

Vax Date: 02/02/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Arm was hurting; Bad injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and HYDRALAZINE HYDROCHLORIDE (DIAZIDE [HYDRALAZINE HYDROCHLORIDE]) for an unknown indication. On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medications provided by the reporter.

Other Meds: LIPITOR; DIAZIDE [HYDRALAZINE HYDROCHLORIDE]

Current Illness: Hypertension

ID: 1580260
Sex: F
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. NO MEDICAL HISTORY WAS GIVEN. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction). At the time of the report, HYPERSENSITIVITY (allergic reaction) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1580261
Sex: F
Age: 51
State: MI

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L208) for COVID-19 vaccination. The patient's past medical history included Diabetic since an unknown date. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), QUETIAPINE FUMARATE (SEROQUEL), GLUCAGON (BAQSIMI), MODAFINIL, TROSPIUM, CLOPIDOGREL BISULFATE (PLAVIX), ATORVASTATIN CALCIUM (LIPITOR), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), BUPROPION HYDROCHLORIDE (WELLBUTRIN), GABAPENTIN, HYDROXYZINE, DULOXETINE HYDROCHLORIDE (CYMBALTA), DICYCLOVERINE HYDROCHLORIDE (BENTYL), FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and INSULIN ASPART (NOVOLOG) for an unknown indication. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm hurt). At the time of the report, PAIN IN EXTREMITY (arm hurt) had not resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Blood glucose decreased: 200 (Inconclusive) sugars were running about 200. On 28-Jan-2021, Blood glucose increased: 300 (Inconclusive) sugars were around 300 and are typically 126. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications provided by the reporter.

Other Meds: ZOLOFT; SEROQUEL; BAQSIMI; MODAFINIL; TROSPIUM; PLAVIX; LIPITOR; ASPIRIN (E.C.); PROTONIX [OMEPRAZOLE]; WELLBUTRIN; GABAPENTIN; HYDROXYZINE; CYMBALTA; BENTYL; ALLEGRA; NOVOLOG

Current Illness: Diabetic

ID: 1580262
Sex: M
Age:
State: FL

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Muscle cramps in back; Feeling a little foggy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling a little foggy) and MUSCLE SPASMS (Muscle cramps in back) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. Concurrent medical conditions included Hypertension and Kidney disorder. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced FEELING ABNORMAL (Feeling a little foggy). On 19-Jan-2021, the patient experienced MUSCLE SPASMS (Muscle cramps in back). On 20-Jan-2021, FEELING ABNORMAL (Feeling a little foggy) had resolved. At the time of the report, MUSCLE SPASMS (Muscle cramps in back) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided. Treatment for the events included Tylenol This case was linked to MOD21-019546, MOD21-041828 (Linked Report). Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: NNI; Sender's Comments: MOD21-019546:crosslinked MOD21-041828:

Other Meds:

Current Illness: Hypertension; Kidney disorder

ID: 1580263
Sex: F
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: wide spread body aches; left bicep red and purple colored.; inflammed lymph nodes down the left side of my body; chills; slight headache; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills) and HEADACHE (slight headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included IBUPROFEN for an unknown indication. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills), HEADACHE (slight headache) and PYREXIA (Slight fever). At the time of the report, PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills), HEADACHE (slight headache) and PYREXIA (Slight fever) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications provided by the reporter.

Other Meds: IBUPROFEN

Current Illness:

ID: 1580264
Sex: F
Age: 78
State: FL

Vax Date: 01/23/2021
Onset Date: 02/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: m their arm was itchy, swelling a little, red and feverish at the injection site; their arm was itchy, swelling a little, red and feverish at the injection site; their arm was itchy, swelling a little, red and feverish at the injection site; their arm was itchy, swelling a little, red and feverish at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (m their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE PRURITUS (their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE SWELLING (their arm was itchy, swelling a little, red and feverish at the injection site) and VACCINATION SITE ERYTHEMA (their arm was itchy, swelling a little, red and feverish at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. Concomitant products included ZINC, VITAMIN C [ASCORBIC ACID] and VITAMIN D [VITAMIN D NOS] for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE WARMTH (m their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE PRURITUS (their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE SWELLING (their arm was itchy, swelling a little, red and feverish at the injection site) and VACCINATION SITE ERYTHEMA (their arm was itchy, swelling a little, red and feverish at the injection site). At the time of the report, VACCINATION SITE WARMTH (m their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE PRURITUS (their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE SWELLING (their arm was itchy, swelling a little, red and feverish at the injection site) and VACCINATION SITE ERYTHEMA (their arm was itchy, swelling a little, red and feverish at the injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. anti-itch cream used as a treatment medication.

Other Meds: ZINC; VITAMIN C [ASCORBIC ACID]; VITAMIN D [VITAMIN D NOS]

Current Illness: Hypertension

ID: 1580265
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: stomach ache after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1580266
Sex: F
Age: 75
State: FL

Vax Date: 01/22/2021
Onset Date: 01/30/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: my left arm started to feel tingly, itchy, hot; my left arm started to feel tingly, itchy, hot; my left arm started to feel tingly, itchy, hot; Red; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (my left arm started to feel tingly, itchy, hot), PRURITUS (my left arm started to feel tingly, itchy, hot), FEELING HOT (my left arm started to feel tingly, itchy, hot) and ERYTHEMA (Red) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PARAESTHESIA (my left arm started to feel tingly, itchy, hot), PRURITUS (my left arm started to feel tingly, itchy, hot), FEELING HOT (my left arm started to feel tingly, itchy, hot) and ERYTHEMA (Red). On 01-Feb-2021, PARAESTHESIA (my left arm started to feel tingly, itchy, hot), PRURITUS (my left arm started to feel tingly, itchy, hot) and FEELING HOT (my left arm started to feel tingly, itchy, hot) had resolved. At the time of the report, ERYTHEMA (Red) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580267
Sex: F
Age: 78
State: IL

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and NAUSEA (nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LEVOTHYROXINE and PARACETAMOL (TYLENOL) for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (headache) and NAUSEA (nausea). At the time of the report, HEADACHE (headache) and NAUSEA (nausea) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Tylenol used as a Treatment Medication.

Other Meds: LEVOTHYROXINE; TYLENOL

Current Illness:

ID: 1580268
Sex: F
Age: 38
State: CA

Vax Date: 08/06/2021
Onset Date: 08/14/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Citrus allergy, hayfever

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Welt on arm for first few days. It seemed to go away and came back itchy and red after a week. It seems to have gotten slightly bigger the last day or two.

Other Meds: Levothyroxine, Multivitamin, Vitamin C, Magnesium

Current Illness: None

ID: 1580269
Sex: M
Age: 75
State: TN

Vax Date: 01/18/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over the body) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No medical history was provided by the reporter. . Concomitant products included ATORVASTATIN, VALSARTAN, FAMOTIDINE, CETIRIZINE, FINASTERIDE, ATENOLOL, HYDROCHLOROTHIAZIDE, CALCITRIOL, APIXABAN and GABAPENTIN for an unknown indication. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PRURITUS (Itching all over the body). At the time of the report, PRURITUS (Itching all over the body) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The treatment information was None + concomitant.

Other Meds: ATORVASTATIN; VALSARTAN; FAMOTIDINE; CETIRIZINE; FINASTERIDE; ATENOLOL; HYDROCHLOROTHIAZIDE; CALCITRIOL; APIXABAN; GABAPENTIN

Current Illness:

ID: 1580270
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Delayed adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Delayed adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Delayed adverse reaction). At the time of the report, VACCINATION COMPLICATION (Delayed adverse reaction) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580271
Sex: F
Age: 66
State: NC

Vax Date: 01/25/2021
Onset Date: 02/02/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: site of the injection was swollen and itching; site of the injection was swollen and itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (site of the injection was swollen and itching) and VACCINATION SITE SWELLING (site of the injection was swollen and itching) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Diabetes mellitus, Blood pressure, Hyperlipidemia and Allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (site of the injection was swollen and itching) and VACCINATION SITE SWELLING (site of the injection was swollen and itching). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (site of the injection was swollen and itching) and VACCINATION SITE SWELLING (site of the injection was swollen and itching) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: ZYRTEC ALLERGY

Current Illness: Allergy; Blood pressure; Diabetes mellitus; Hyperlipidemia

ID: 1580272
Sex: F
Age: 73
State: CA

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: SORE ARM; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (SORE ARM). On 29-Jan-2021, PAIN IN EXTREMITY (SORE ARM) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, Heart rate: (High) HR is higher than normal (from 60 to 80). The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580273
Sex: M
Age: 24
State: CA

Vax Date: 01/04/2021
Onset Date: 01/10/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: positive for COVID-19; fever; worse cough; body aches; chills; sore throat; minor cough; This spontaneous case was reported by a physician and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (minor cough), COUGH (worse cough), COVID-19 (positive for COVID-19) and PAIN (body aches) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and COUGH (minor cough). On 11-Jan-2021, the patient experienced COUGH (worse cough), PAIN (body aches) and CHILLS (chills). On 13-Jan-2021, the patient experienced COVID-19 (positive for COVID-19) and PYREXIA (fever). The patient was treated with VITAMINS NOS at a dose of 1 dosage form; GUAIFENESIN (MUCINEX) at a dose of 1 dosage form; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at a dose of 1 dosage form; DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at a dose of 1 dosage form; DEXAMETHASONE at a dose of 1 dosage form and AZITHROMYCIN at a dose of 1 dosage form. At the time of the report, OROPHARYNGEAL PAIN (sore throat), COUGH (minor cough), COUGH (worse cough), COVID-19 (positive for COVID-19), PAIN (body aches), CHILLS (chills) and PYREXIA (fever) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, SARS-CoV-2 test: (Inconclusive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580274
Sex: U
Age: 80
State: IN

Vax Date: 01/20/2021
Onset Date: 01/26/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: red rash at the injection site; itchy at the injection site; warm to the touch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (red rash at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE WARMTH (warm to the touch at injection site) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE RASH (red rash at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE WARMTH (warm to the touch at injection site). At the time of the report, VACCINATION SITE RASH (red rash at the injection site) and VACCINATION SITE WARMTH (warm to the touch at injection site) had not resolved and VACCINATION SITE PRURITUS (itchy at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580275
Sex: F
Age: 31
State: IL

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Flushing; Dizzy; Tongue was swollen; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FLUSHING (Flushing), DIZZINESS (Dizzy), SWOLLEN TONGUE (Tongue was swollen) and CHILLS (Chills) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for an unknown indication. No Medical History information was reported. On 09-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced FLUSHING (Flushing), DIZZINESS (Dizzy), SWOLLEN TONGUE (Tongue was swollen) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at a dose of 1 dosage form and NAPROXEN at a dose of 500 milligram twice a day. At the time of the report, FLUSHING (Flushing), DIZZINESS (Dizzy), SWOLLEN TONGUE (Tongue was swollen) and CHILLS (Chills) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, Heart rate: (High) went to the ER for her heart rate since it was elevated in 130-140s. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1580276
Sex: M
Age:
State: PA

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: get a headache from neck surgery once in a while; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (get a headache from neck surgery once in a while) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Neck surgery. On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (get a headache from neck surgery once in a while). At the time of the report, HEADACHE (get a headache from neck surgery once in a while) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580277
Sex: F
Age: 66
State: IL

Vax Date: 01/19/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Arm is hard, red and hot at the injection site, about the size of a softball; Arm is hardt at the injection site, about the size of a softball; Arm is hard, red and hot at the injection site, about the size of a softball; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm is hard, red and hot at the injection site, about the size of a softball), VACCINATION SITE INDURATION (Arm is hardt at the injection site, about the size of a softball) and VACCINATION SITE ERYTHEMA (Arm is hard, red and hot at the injection site, about the size of a softball) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Arm is hard, red and hot at the injection site, about the size of a softball), VACCINATION SITE INDURATION (Arm is hardt at the injection site, about the size of a softball) and VACCINATION SITE ERYTHEMA (Arm is hard, red and hot at the injection site, about the size of a softball). At the time of the report, VACCINATION SITE WARMTH (Arm is hard, red and hot at the injection site, about the size of a softball), VACCINATION SITE INDURATION (Arm is hardt at the injection site, about the size of a softball) and VACCINATION SITE ERYTHEMA (Arm is hard, red and hot at the injection site, about the size of a softball) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1580278
Sex: F
Age: 65
State: TX

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: The rash continues; Injection site itching; injection site is still red; Hives from injection site down to the elbow; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (The rash continues), VACCINATION SITE URTICARIA (Hives from injection site down to the elbow), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE PAIN (Soreness) and VACCINATION SITE ERYTHEMA (injection site is still red) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The patient's past medical history included Hives (Patient had hives 3 times and after her child was born 2 other times.). Family history included Autoimmune disorder (history of autoimmunity in her family.) since an unknown date. Concurrent medical conditions included Seasonal allergy. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness). On 23-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Hives from injection site down to the elbow). On 24-Jan-2021, the patient experienced RASH (The rash continues), VACCINATION SITE PRURITUS (Injection site itching) and VACCINATION SITE ERYTHEMA (injection site is still red). On 24-Jan-2021, VACCINATION SITE URTICARIA (Hives from injection site down to the elbow) had resolved. At the time of the report, RASH (The rash continues), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE PAIN (Soreness) and VACCINATION SITE ERYTHEMA (injection site is still red) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication include something for the thyroid. No treatment information was reported.

Other Meds:

Current Illness: Autoimmune disorder (history of autoimmunity in her family.); Seasonal allergy

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm